Article
Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.
EBioMedicine - 1 Jan 2026
Montellier Emilie, Manches Olivier, Gaucher Jonathan, Freycon Claire, Hoyos David, Blanchet Sandrine, Verboom Murielle, Dutzmann Christina M, Coutant Sophie, Bou Jacqueline, Fin Bertrand, Olaso Robert, Deleuze Jean-François, Frébourg Thierry, Greenbaum Benjamin D, Levine Arnold J, Kratz Christian P, Bougeard Gaëlle, Hainaut Pierre
Abstract excerpt
BACKGROUND: Li-Fraumeni Syndrome (LFS) is a heterogenous cancer predisposition condition caused by pathogenic TP53 variants, characterised by a lifelong high risk of a broad spectrum of cancers. Certain pathogenic TP53 variants have been shown be immunogenic in a somatic context. Whether neoantigenicity contributes to LFS heterogeneity is unknown. In this study we analysed the correlations between predicted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
